AJJ Medtech Holdings Limited (SGX:584)

AJJ Medtech Holdings Income Statement

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2.93	2.32	1.62	0.6	0.32	0.68
Revenue	2.93	2.32	1.62	0.6	0.32	0.68
Revenue Growth (YoY)	15.42%	43.84%	170.97%	86.83%	-53.29%	229.95%
Cost of Revenue	1.79	1.74	0.92	0.28	0.05	-
Gross Profit	1.14	0.59	0.7	0.31	0.27	0.68
Selling, General & Admin	4.35	4.55	3.27	4.28	4.37	2.54
Other Operating Expenses	0.1	-0.07	-0.06	-0.08	-0.18	0.92
Operating Expenses	4.45	4.48	3.21	4.19	4.19	3.46
Operating Income	-3.31	-3.89	-2.51	-3.88	-3.92	-2.78
Interest Expense	-0.07	-0.05	-0.06	-0.06	-0.08	-0.1
EBT Excluding Unusual Items	-3.38	-3.95	-2.57	-3.94	-3.99	-2.88
Gain (Loss) on Sale of Assets	-	-	-	-	1.88	-
Asset Writedown	-	-	-	-0.05	-	-
Legal Settlements	-	-	-	-	0.37	-
Other Unusual Items	0.01	0.08	0	0.01	-	0.07
Pretax Income	-3.37	-3.87	-2.56	-3.98	-1.74	-2.81
Income Tax Expense	-0	-0	-0.01	-0.28	-0	-0
Earnings From Continuing Operations	-3.37	-3.87	-2.56	-3.7	-1.73	-2.8
Earnings From Discontinued Operations	-	-	0.03	-0.54	-	-
Net Income to Company	-3.37	-3.87	-2.53	-4.24	-1.73	-2.8
Minority Interest in Earnings	-	-	-	-	0.04	0.03
Net Income	-3.37	-3.87	-2.53	-4.24	-1.7	-2.77
Net Income to Common	-3.37	-3.87	-2.53	-4.24	-1.7	-2.77
Shares Outstanding (Basic)	1,503	1,367	934	934	934	770
Shares Outstanding (Diluted)	1,503	1,367	934	934	934	770
Shares Change (YoY)	22.77%	46.39%	-	-	21.32%	15.18%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-0.48	-1.62	-1.74	-3.24	-6.04	-1.17
Free Cash Flow Per Share	-	-0.00	-0.00	-0.00	-0.01	-0.00
Gross Margin	38.82%	25.27%	43.28%	52.35%	84.95%	100.00%
Operating Margin	-113.26%	-167.63%	-155.29%	-651.17%	-1228.53%	-406.59%
Profit Margin	-115.17%	-166.38%	-156.47%	-711.58%	-531.66%	-405.71%
Free Cash Flow Margin	-16.37%	-69.91%	-107.93%	-543.29%	-1894.67%	-171.60%
EBITDA	-3.2	-3.75	-2.33	-3.64	-3.74	-2.38
EBITDA Margin	-109.47%	-161.60%	-144.21%	-	-	-
D&A For EBITDA	0.11	0.14	0.18	0.24	0.18	0.4
EBIT	-3.31	-3.89	-2.51	-3.88	-3.92	-2.78
EBIT Margin	-113.26%	-167.63%	-155.29%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.